Terns Pharmaceuticals Inc...
4.67
0.10 (2.19%)
At close: Jan 15, 2025, 1:20 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -5.13 -6.08 -3.56 -11.39 -6.71 -24.89
PS Ratio n/a n/a 178.65 n/a n/a n/a
PB Ratio 1.81 1.32 1.11 6.74 109.70 6.10
P/FCF Ratio -6.86 -7.43 -4.24 -15.2 -6.88 -24.07
P/OCF Ratio -6.86 -7.47 -4.27 -15.5 -6.97 -24.39
OCF/S Ratio n/a n/a -41.83 n/a n/a n/a
Debt / Equity Ratio 0.00 0.00 n/a 0.19 n/a n/a
Quick Ratio 22.39 33.68 24.48 3.85 4.49 37.25
Current Ratio 22.39 33.68 24.48 3.98 4.49 37.25
Asset Turnover n/a n/a 0.01 n/a n/a n/a
Interest Coverage n/a n/a n/a n/a n/a n/a
Return on Equity (ROE) -0.35 -0.22 -0.31 -0.59 -16.36 -0.25
Return on Assets (ROA) -0.34 -0.21 -0.3 -0.44 -2.88 -0.2
Return on Capital (ROIC) -0.4 -0.22 -0.31 -0.53 -3.7 -0.21
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a 48.80% n/a n/a n/a
Net Profit Margin n/a n/a -5.02K% n/a n/a n/a
Pretax Profit Margin n/a n/a -4.96K% n/a n/a n/a
Operating Profit Margin n/a n/a -4.99K% n/a n/a n/a
FCF Margin n/a n/a -4.22K% n/a n/a n/a
EBITDA Margin n/a n/a -4.93K% n/a n/a n/a